Form D · Other
CFX Labs Inc.
Chicago, IL · CIK 0001912575
Offering snapshot reported Dec 26, 2024 · SEC filing
- Reported sold
- $14M Offering amount: $14M
- Investors reported
- 79 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 13, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 26, 2024 | Initial | $14,012,518 | No comparison | 79 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-533377
Source: Form D, filed Dec 26, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nicholas Cavet | Director, Executive |
| Sam Hallene | Director |
| Benjamin Ng | Director, Executive |
| Brian Walls | Director |
| Sam Yagan | Director |
Issuer details
Industry: Other (See others in industry)
Address:
2045 W Grand Ave Ste B Pmb 71816
Chicago, IL, 60612
Chicago, IL, 60612